Therefore, this study was conducted to explore the expression of CCL28 in AD and BA, hence its pathogenic role in such diseases to identify the clinical relevance of measuring serum CCL28 in terms of disease activity and/or severity. This evidence concerns the gene CCL28 and Alzheimer disease.